KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis.

Saved in:
Bibliographic Details
Title: KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis.
Authors: Sigafoos AN; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Tolosa EJ; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Carr RM; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Fernandez-Barrena MG; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Almada LL; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Pease DR; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Hogenson TL; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Raja Arul GL; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Mousavi F; Department of Physiology and Pharmacology, University of Western Ontario, London, Canada.; Department of Oncology, University of Western Ontario, London, Canada., Sen S; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Vera RE; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Marks DL; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Flores LF; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., LaRue-Nolan KC; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Wu C; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Bamlet WR; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Vrabel AM; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Sicotte H; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Schenk EL; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Smyrk TC; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., Zhang L; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., Rabe KG; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Oberg AL; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Zaphiropoulos PG; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden., Chevet E; Université de Rennes, CEDEX, Rennes, France., Graham RP; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., Hagen CE; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., di Magliano MP; Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, Michigan., Elsawa SF; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.; Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, New Hampshire., Pin CL; Department of Physiology and Pharmacology, University of Western Ontario, London, Canada.; Department of Oncology, University of Western Ontario, London, Canada., Mao J; University of Massachusetts Medical School, Worcester, Massachusetts., McWilliams RR; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Fernandez-Zapico ME; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.
Source: Cancer research communications [Cancer Res Commun] 2024 Jul 01; Vol. 4 (7), pp. 1677-1689.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2767-9764
DOI:10.1158/2767-9764.CRC-23-0464